Arcadia Investment Management’s Biogen BIIB Stock Holding History

Arcadia Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-150	Closed	-$41K	–	373
2017 Q1	$41K	Hold	150	–	–	0.01%	233
2016 Q4	$43K	Hold	150	–	–	0.01%	216
2016 Q3	$47K	Hold	150	–	–	0.02%	201
2016 Q2	$36K	Hold	150	–	–	0.01%	236
2016 Q1	$39K	Hold	150	–	–	0.01%	182
2015 Q4	$46K	Hold	150	–	–	0.01%	172
2015 Q3	$43K	Hold	150	–	–	0.01%	149
2015 Q2	$60K	Buy	+150	New	+$60.2K	0.02%	152

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Arcadia Investment Management's BIIB Position: Q2 2017 in Review

Arcadia Investment Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 150 shares — an estimated $41K sold.

Arcadia Investment Management first reported a position in BIIB in Q2 2015 and held it in 8 quarters. The position peaked at $60K in Q2 2015. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Arcadia Investment Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
Arcadia Investment Management sold 150 Biogen shares in Q2 2017, an estimated $41K.
Arcadia Investment Management first reported a position in Biogen in Q2 2015 and held it in 8 quarters.
Arcadia Investment Management's Biogen position peaked at $60K in Q2 2015.
993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Arcadia Investment Management's 13F filing for Q2 2017, filed 3 Aug 2017.